|
at 16:01 |
|
|
Expanded Phase 1 monotherapy study of givastomig, a Claudin 18.2 X 4-1BB bispecific antibody immunostimulant, shows promising single-agent activity in heavily pre-treated patients with gastric cancers expressing Claudin 18.2 at low and high levelsThe...
|
|
at 15:52 |
|
|
Tower Health ("Tower Health") today announced the results of its offer to exchange (the "Exchange Offer") all or any portion of certain outstanding debt securities issued by or on behalf of Tower Health described in the table below (collectively, the...
|
|
at 15:25 |
|
|
National optical retailer Eyemart Express announced today that CEO Mike Nuzzo will participate in a fireside chat on the Innovation Stage at Vision Expo West in Las Vegas on Thursday, Sept. 19, at 4pm Pacific Daylight Time....
|
|
at 14:45 |
|
|
The Foundation Fighting Blindness, the driving force in the global development of treatments and cures for blinding diseases, presents the Chicago Night for Sight event on Saturday, October 5, 2024, at The Ritz-Carlton, Chicago. This event will raise...
|
|
at 14:34 |
|
|
DisposeRx, Inc. is proud to announce the sale of its Coaches vs Overdoses, LLC. to Pennant, LLC. This innovative initiative, developed and nurtured by DisposeRx, has made significant strides in helping to combat the opioid epidemic through raising...
|
|
at 14:13 |
|
|
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) is pleased to announce the 2024 honorees of the Heroes of Military Medicine - San Antonio Awards....
|
|
|
